Halozyme Therapeutics, Inc.

Pacer Advisors, Inc. HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/24/2026

Shares

937,293

Value ($000)

63,080

Weight

0.2%

2020 Q3 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/24/2026	63,080	0.2%	937,293	12/31/2025
2025 Q3	10/15/2025	35,121	0.1%	478,874	9/30/2025
2025 Q2	8/12/2025	1,156	0.0%	22,225	6/30/2025
2025 Q1	5/6/2025	740	0.0%	11,594	3/31/2025
2024 Q4	1/22/2025	1,387	0.0%	29,006	12/31/2024
2024 Q3	11/12/2024	1,675	0.0%	29,261	9/30/2024
2024 Q2	8/13/2024	1,542	0.0%	29,446	6/30/2024
2024 Q1	5/10/2024	1,136	0.0%	27,916	3/31/2024
2023 Q4	1/16/2024	975	0.0%	26,376	12/31/2023
2023 Q3	11/13/2023	425	0.0%	11,115	9/30/2023
2023 Q2	7/12/2023	1,204	0.0%	33,380	6/30/2023
2023 Q1	5/2/2023	317	0.0%	8,300	3/31/2023
2022 Q4	2/6/2023	1,475	0.0%	25,916	12/31/2022
2022 Q3	10/18/2022	233	0.0%	5,895	9/30/2022
2021 Q4	2/3/2022	600	0.0%	14,912	12/31/2021
2021 Q3	10/15/2021	795	0.0%	19,552	9/30/2021
2021 Q2	7/21/2021	630	0.0%	13,884	6/30/2021
2021 Q1	4/5/2021	656	0.0%	15,743	3/31/2021
2020 Q4	1/20/2021	494	0.0%	11,578	12/31/2020
2020 Q3	10/19/2020	121	0.0%	4,606	9/30/2020